Risk factors for dementia in the context of cardiovascular disease: A protocol of an overview of reviews.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
10
02
2022
accepted:
01
07
2022
entrez:
21
7
2022
pubmed:
22
7
2022
medline:
26
7
2022
Statut:
epublish
Résumé
Dementia is a major public health priority. Although there is abundant evidence of an association between dementia and poor cardiovascular health, findings have been inconsistent and uncertain in identifying which factors increase dementia risk in those with cardiovascular disease. Indeed, multiple variables including sociodemographic, economic, health, lifestyle and education may indicate who is at higher vs. lower dementia risk and could be used in prediction modelling. Therefore, the aim of this review is to synthesise evidence on the key risk factors for dementia in those with a history of cardiovascular disease. This is an overview of reviews protocol, registered on PROSPERO (CRD42021265363). Four electronic databases including MEDLINE, EMBASE, PsycINFO, and the Cochrane Database of Systematic Reviews will be searched. Studies will be included if they are systematic reviews and/or meta-analyses that have investigated the risk of incident dementia (all-cause and subtypes including Alzheimer's disease and vascular dementia) in people with a history of coronary heart disease, heart failure, atrial fibrillation, hypertension, hyperlipidaemia, and vascular stiffness. Study selection will be completed by two independent researchers according to the eligibility criteria, and conflicts resolved by a third reviewer. References will be exported into Covidence for title and abstract sifting, full-text review, and data extraction. Methodological quality will be assessed using the AMSTAR-2 criteria and confidence of evidence will be assessed using the GRADE classification. This overview of reviews will follow PRISMA guidelines. If there is sufficient homogeneity in the data, the results will be pooled, and a meta-analysis conducted to determine the strength of association between each risk factor and incident all-cause dementia and its subtypes for each cardiovascular diagnoses separately. We will create a comprehensive summary of the key risk factors linking cardiovascular diseases to risk of incident dementia. This knowledge is essential for informing risk predictive model development as well as the development of risk reduction and prevention strategies.
Sections du résumé
BACKGROUND
Dementia is a major public health priority. Although there is abundant evidence of an association between dementia and poor cardiovascular health, findings have been inconsistent and uncertain in identifying which factors increase dementia risk in those with cardiovascular disease. Indeed, multiple variables including sociodemographic, economic, health, lifestyle and education may indicate who is at higher vs. lower dementia risk and could be used in prediction modelling. Therefore, the aim of this review is to synthesise evidence on the key risk factors for dementia in those with a history of cardiovascular disease.
METHODS
This is an overview of reviews protocol, registered on PROSPERO (CRD42021265363). Four electronic databases including MEDLINE, EMBASE, PsycINFO, and the Cochrane Database of Systematic Reviews will be searched. Studies will be included if they are systematic reviews and/or meta-analyses that have investigated the risk of incident dementia (all-cause and subtypes including Alzheimer's disease and vascular dementia) in people with a history of coronary heart disease, heart failure, atrial fibrillation, hypertension, hyperlipidaemia, and vascular stiffness. Study selection will be completed by two independent researchers according to the eligibility criteria, and conflicts resolved by a third reviewer. References will be exported into Covidence for title and abstract sifting, full-text review, and data extraction. Methodological quality will be assessed using the AMSTAR-2 criteria and confidence of evidence will be assessed using the GRADE classification. This overview of reviews will follow PRISMA guidelines. If there is sufficient homogeneity in the data, the results will be pooled, and a meta-analysis conducted to determine the strength of association between each risk factor and incident all-cause dementia and its subtypes for each cardiovascular diagnoses separately.
DISCUSSION
We will create a comprehensive summary of the key risk factors linking cardiovascular diseases to risk of incident dementia. This knowledge is essential for informing risk predictive model development as well as the development of risk reduction and prevention strategies.
Identifiants
pubmed: 35862400
doi: 10.1371/journal.pone.0271611
pii: PONE-D-22-04170
pmc: PMC9302739
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0271611Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Intern Med. 2014 Mar;275(3):229-50
pubmed: 24605807
BMC Med Res Methodol. 2018 Jan 10;18(1):5
pubmed: 29316881
Lancet Neurol. 2020 Jun;19(6):533-543
pubmed: 32470425
Curr Cardiol Rep. 2017 Aug 11;19(9):87
pubmed: 28801790
Ther Adv Chronic Dis. 2017 Aug;8(8-9):121-136
pubmed: 28815009
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
JMIR Ment Health. 2014 Dec 22;1(1):e4
pubmed: 26543904
Int J Evid Based Healthc. 2015 Sep;13(3):163-9
pubmed: 26262566
Adv Med Educ Pract. 2017 Aug 21;8:603-609
pubmed: 28860891
Curr Drug Targets. 2018;19(9):1038-1044
pubmed: 29623835
Syst Rev. 2017 Nov 21;6(1):231
pubmed: 29162130
J Am Heart Assoc. 2019 Oct;8(19):e013154
pubmed: 31549581
J Alzheimers Dis. 2014;42(1):119-35
pubmed: 24799342
Lancet Neurol. 2018 May;17(5):434-444
pubmed: 29555425
Neurology. 2007 Oct 2;69(14):1442-50
pubmed: 17909157
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Alzheimers Res Ther. 2020 Aug 7;12(1):94
pubmed: 32767997
Alzheimers Res Ther. 2016 Jul 30;8(1):23
pubmed: 27473681
Clin Epidemiol. 2018 Sep 18;10:1233-1247
pubmed: 30271219
BMJ Open. 2019 Jan 25;9(1):e022846
pubmed: 30782689
JAMA. 2022 Apr 19;327(15):1488-1495
pubmed: 35438728
Alzheimers Dement. 2013 Jan;9(1):63-75.e2
pubmed: 23305823
Syst Rev. 2021 Sep 23;10(1):254
pubmed: 34556172
Int J Evid Based Healthc. 2015 Sep;13(3):132-40
pubmed: 26360830
Evid Based Ment Health. 2018 Aug;21(3):95-100
pubmed: 30006442
PLoS One. 2017 Sep 8;12(9):e0184244
pubmed: 28886155
Am J Geriatr Psychiatry. 2008 May;16(5):343-54
pubmed: 18448847
BMJ. 2017 Sep 21;358:j4008
pubmed: 28935701
Front Cardiovasc Med. 2020 Jan 31;7:5
pubmed: 32083095
Gerontol Geriatr Med. 2021 Feb 05;7:2333721421993747
pubmed: 33614833
BMC Med Res Methodol. 2012 Apr 18;12:51
pubmed: 22512835
Lancet Neurol. 2010 Aug;9(8):793-806
pubmed: 20650401
Syst Rev. 2018 Oct 12;7(1):159
pubmed: 30314530
JAMA. 2018 Aug 21;320(7):657-664
pubmed: 30140876
BMJ. 2019 Aug 7;366:l4414
pubmed: 31391187
Eur J Pharmacol. 2008 May 6;585(1):97-108
pubmed: 18395201
Alzheimers Dement. 2018 May;14(5):601-609
pubmed: 29169013
J Prev Alzheimers Dis. 2020;7(4):294-298
pubmed: 32920634
Lancet Neurol. 2016 Apr;15(5):455-532
pubmed: 26987701
Biomol Ther (Seoul). 2018 Nov 1;26(6):521-532
pubmed: 30464071
Neurol Res. 2004 Jul;26(5):563-6
pubmed: 15265275
Alzheimer Dis Assoc Disord. 2009 Jan-Mar;23(1):1-10
pubmed: 18703981
Syst Rev. 2018 Mar 1;7(1):39
pubmed: 29490699
Eur Heart J. 2018 Sep 1;39(33):3119-3125
pubmed: 29901708
Eur J Epidemiol. 2019 Sep;34(9):889-890
pubmed: 31222608
Arch Neurol. 2009 Mar;66(3):336-42
pubmed: 19273752
J Alzheimers Dis. 2021;80(1):337-355
pubmed: 33554910
Alzheimers Dement. 2018 Nov;14(11):1493-1504
pubmed: 29494808
Alzheimers Dement (N Y). 2018 Oct 05;4:510-520
pubmed: 30364652
PLoS Med. 2020 Dec 15;17(12):e1003474
pubmed: 33320852
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120